Practices of Lyme disease diagnosis and treatment by general practitioners in Quebec, 2008-2015

BMC Family Practice

Volumn 18, Issue 1, 2017, Pages

  Gasmi, Salima ^a,b   Ogden, Nicholas H ^c,d   Leighton, Patrick A ^e   Adam Poupart, Ariane ^a   Milord, François ^a   Lindsay, L Robbin ^c   Barkati, Sapha ^e   Thivierge, Karine ^a  

^a INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d Groupe de Recherche en Epidémiologie des Zoonoses en SantéPublique GREZOSP   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Canada; Diagnosis; Ixodes scapularis; Lyme disease; Prophylaxis; Treatment

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; CLINICAL PRACTICE; COMPLICATION; GENERAL PRACTITIONER; HUMAN; IXODES; LYME DISEASE; QUEBEC; QUESTIONNAIRE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; TICK BITE;

ANIMALS; ANTI-INFECTIVE AGENTS; GENERAL PRACTITIONERS; HUMANS; IXODES; LYME DISEASE; PRACTICE PATTERNS, PHYSICIANS'; QUEBEC; RETROSPECTIVE STUDIES; SURVEYS AND QUESTIONNAIRES; TICK BITES;

EID: 85019895810     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/s12875-017-0636-y     Document Type: Article

References (31)

1. Ogden N, Koffi J, Pelcat Y, Lindsay L. Environmental risk from Lyme disease in centeral and eastern Canada: a summary of recent surveillance information. CCDR. 2014;40:74-83.
2. Leighton PA, Koffi J, Pelcat Y, Lindsay LR, Ogden NH. Predicting the speed of tick invasion: an empirical model of range expansion for the Lyme disease vector Ixodes scapularis in Canada. J App Ecol. 2012;49(2):457-64.
3. Government of Canada. Canada’s surveillance of Lyme disease, 2015. Available at: http://www.healthycanadians.gc.ca/diseases-conditions-maladies-affections/disease-maladie/lyme/surveillance-eng.php. Accessed Nov 25 2016.
4. Institut national de santé publique du Québec (INSPQ). Rapport de surveillance de la maladie de Lyme : année 2015. Available at: http://www.inspq.qc.ca/publications/2190 Accessed Nov 25 2016.
5. Milord F, Leblanc MA, Markowski F, Rousseau M, Lévesque S, Dion R. Flash Vigie : Surveillance de la maladie de Lyme au Québec. Bilan 2004-2012. Ministère de la santé et des Services sociaux, 2014
6. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease, United States, 1992-2006. MMWR Surveill Summ. 2008;57(10):1-9.
7. Kuschak T. The laboratory diagnosis of lyme borreliosis: guidelines from the Canadian public health laboratory network. Can J Infect Dis Med Microbiol. 2007;18(2):145-8.
8. Wormser GP. Hematogenous dissemination in early Lyme disease. Wien Klin Wochenschr. 2006;118(21-22):634-7.
9. Hatchette TF, Davis I, Johnston BL. Inside This issue: clinical aspects of Lyme disease. CCDR. 2014;40:11.
10. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious diseases society of America. Clin Infect Dis. 2006;43(9):1089-134.
11. Bunikis J, Barbour AG. Laboratory testing for suspected Lyme disease. Med Clin North Am. 2002;86:311-40.
12. Lindsay L, Bernat K, Dibernardo A. Laboratory diagnostics for Lyme disease. CCDR. 2014;40:232-41.
13. Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease. Clin Infect Dis. 2001;33(6):780-5.
14. Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. J Am Med Assoc. 1993;269(14):1812-6.
15. Magri JM, Johnson MT, Herring TA, Greenblatt JF. Lyme disease knowledge, beliefs, and practices of New Hampshire primary care physicians. J Am Board Fam Pract. 2002;15(4):277-84.
16. Ferrouillet C, Milord F, Lambert L, Vibien A, Ravel A. Lyme disease: knowledge and practices of family practitioners in southern Quebec. Can J Infect Dis Med Microbiol. 2015;26(3):151-6.
17. Henry B, Crabtree A, Roth D, Blackman D, Morshed M. Lyme disease Knowledge, beliefs, and practices of physicians in a low-endemic area. Can Fam Phys. 2012;58(5):e289-95.
18. Fix AD, Strickland GT, Grant J. Tick bites and Lyme disease in an endemic setting: problematic use of serologic testing and prophylactic antibiotic therapy. J Am Med Assoc. 1998;279(3):206-10.
19. Dibernardo A, Cote T, Ogden NH, Lindsay LR. The prevalence of Borrelia miyamotoi infection, and co-infections with other Borrelia spp. in Ixodes scapularis ticks collected in Canada. Parasit Vectors. 2014;7(1):1-8.
20. Lambert L, Drapeau M, Milord F, Sehrir B, Trudel L, Doucet A. Guide d’intervention. La maladie de Lyme In Santé et service sociaux, 2013. Available at: http://publications.msss.gouv.qc.ca/msss/document-000291/. Accessed Nov 25 2016.
21. Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med. 1996;100(5):502-8.
22. Reid MC, Schoen RT, Evans J, Rosenberg JC, Horwitz RI. The consequences of overdiagnosis and overtreatment of Lyme disease: an observational study. Ann Intern Med. 1998;128(5):354-62.
23. Magid D, Schwartz B, Craft J, Schwartz JS. Prevention of Lyme disease after tick bites: a cost-effectiveness analysis. N Engl J Med. 1992;327(8):534-41.
24. Dowell SF, Schwartz B. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Phys. 1997;55(5):1647-54.
25. Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, et al. Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection. PLoS One. 2012;7(1):e29914.
26. Meek JI, Roberts CL, Smith EV, Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. J Public Health Manag Pract. 1996;2(4):61-5.
27. Aucott J, Morrison C, Munoz B, Rowe PC, Schwarzwalder A, West SK. Diagnostic challenges of early Lyme disease: lessons from a community case series. BMC Infect Dis. 2009;9(1):1.
28. Sood SK, Salzman MB, Johnson BJ, Happ CM, Feig K, Carmody L, et al. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic. J Infect Dis. 1997;175(4):996-9.
29. Huegli D, Moret J, Rais O, Moosmann Y, Erard P, Malinverni R, et al. Prospective study on the incidence of infection by Borrelia burgdorferi sensu lato after a tick bite in a highly endemic area of Switzerland. Ticks Tick Borne Dis. 2011;2(3):129-36.
30. Ramsey AH, Belongia EA, Chyou PH, Davis JP. Appropriateness of Lyme disease serologic testing. Ann Fam Med. 2004;2(4):341-4.
31. Perea A, Hinckley A, Mead P. Tick bite prophylaxis: results from a 2012 survey of healthcare providers. Zoonoses Public Health. 2015;62(5):388-92.